Clinuvel Pharmaceuticals (CLVLY) Short Interest Ratio & Short Volume $6.43 -0.44 (-6.34%) As of 06/18/2025 01:39 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock Clinuvel Pharmaceuticals Short Interest DataClinuvel Pharmaceuticals (CLVLY) has a short interest of 6,300 shares. This marks a 3.28% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.0, indicating that it would take 9.0 days of the average trading volume of 2,015 shares to cover all short positions.Current Short Interest6,300 sharesPrevious Short Interest6,100 sharesChange Vs. Previous Month+3.28%Dollar Volume Sold Short$44.98 thousandShort Interest Ratio9.0 Days to CoverLast Record DateMay 31, 2025Today's Trading Volume153 sharesAverage Trading Volume2,015 sharesToday's Volume Vs. Average8% Short Selling Clinuvel Pharmaceuticals? Sign up to receive the latest short interest report for Clinuvel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLVLY Short Interest Over TimeCLVLY Days to Cover Over TimeCLVLY Percentage of Float Shorted Over Time Clinuvel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20256,300 shares $44.98 thousand +3.3%N/A9 $7.14 5/15/20256,100 shares $42.70 thousand -15.3%N/A4.4 $7.00 4/30/20257,200 shares $51.84 thousand -1.4%N/A4.8 $7.20 4/15/20257,300 shares $51.10 thousand +151.7%N/A1.2 $7.00 3/31/20252,900 shares $20.59 thousand -9.4%N/A2.4 $7.10 3/15/20253,200 shares $23.36 thousand -67.7%N/A1 $7.30 2/28/20259,900 shares $70.44 thousand -19.5%N/A1.7 $7.12 2/15/202512,300 shares $92.25 thousand +11.8%N/A3.5 $7.50 1/31/202511,000 shares $84.15 thousand +46.7%N/A5 $7.65 1/15/20257,500 shares $55.43 thousand -38.5%N/A0.8 $7.39 Get the Latest News and Ratings for CLVLY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clinuvel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202412,200 shares $93.94 thousand +144.0%N/A2.3 $7.70 12/15/20245,000 shares $39.53 thousand -27.5%N/A0.6 $7.91 11/30/20246,900 shares $59.34 thousand +146.4%N/A1.1 $8.60 11/15/20242,800 shares $24.47 thousand +1,300.0%N/A0.5 $8.74 10/31/2024200 shares $1.91 thousand -86.7%N/A0.1 $9.53 10/15/20241,500 shares $14.63 thousand +200.0%N/A1.2 $9.75 9/30/2024500 shares $4.75 thousand No ChangeN/A0.1 $9.50 9/15/2024500 shares $5 thousand +66.7%N/A0.2 $10.00 8/31/2024300 shares $3.09 thousand -82.4%N/A0.1 $10.30 8/15/20241,700 shares $15.64 thousand -34.6%N/A1 $9.20 7/31/20242,600 shares $25.71 thousand +333.3%N/A1.6 $9.89 7/15/2024600 shares $6.21 thousand +200.0%N/A0.1 $10.35 6/30/2024200 shares $1.96 thousand -50.0%N/A0.1 $9.80 6/15/2024400 shares $4.04 thousand +100.0%N/A0.2 $10.11 5/31/2024200 shares $2.07 thousand -66.7%N/A0.1 $10.36 5/15/2024600 shares $6.12 thousand +500.0%N/A0.1 $10.20 4/30/2024100 shares $980.00 -98.2%N/A0 $9.80 4/15/20245,500 shares $55.50 thousand +41.0%N/A0.8 $10.09 3/31/20243,900 shares $36.89 thousand +680.0%N/A0.7 $9.46 3/15/2024500 shares $5 thousand -16.7%N/A0 $10.00 2/29/2024600 shares $5.20 thousand +500.0%N/A0 $8.67 2/15/2024100 shares $992.00 -93.3%N/A0 $9.92 12/15/20231,700 shares $18.85 thousand -59.5%N/A0.5 $11.09 11/30/20234,200 shares $49.41 thousand +31.3%N/A2.2 $11.77 11/15/20233,200 shares $34.72 thousand +14.3%N/A2.1 $10.85 10/31/20232,800 shares $27.58 thousand +16.7%N/A0.8 $9.85 10/15/20232,400 shares $24 thousand +1,100.0%N/A0.6 $10.00 9/30/2023200 shares $1.94 thousand -94.4%N/A0 $9.68 9/15/20233,600 shares $38.52 thousand No ChangeN/A0.3 $10.70 7/31/20233,600 shares $44.10 thousand -10.0%N/A0.5 $12.25379 passengers walked away from this (Ad)Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists[See The Details Here] 7/15/20234,000 shares $48.96 thousand +66.7%N/A0.8 $12.24 6/30/20232,400 shares $28.74 thousand -41.5%N/A0.3 $11.98 6/15/20234,100 shares $52.23 thousand +4,000.0%N/A0.2 $12.74 5/31/2023100 shares $1.20 thousand No ChangeN/A0 $11.98 5/15/2023100 shares $1.31 thousand No ChangeN/A0 $13.11 4/30/2023100 shares $1.33 thousand -93.3%N/A0 $13.25 4/15/20231,500 shares $20.96 thousand -31.8%N/A0.9 $13.97 3/31/20232,200 shares $27.94 thousand -73.5%N/A0.7 $12.70 3/15/20238,300 shares $104.66 thousand +822.2%N/A1.1 $12.61 2/28/2023900 shares $11.61 thousand -60.9%N/A0.2 $12.90 2/15/20232,300 shares $37.72 thousand +130.0%N/A0.4 $16.40 1/31/20231,000 shares $17.45 thousand -50.0%N/A0.1 $17.45 1/15/20232,000 shares $34.01 thousand No ChangeN/A0.3 $17.01 12/30/20222,000 shares $29.47 thousand -28.6%N/A0.4 $14.74 12/15/20222,800 shares $39.87 thousand -86.0%N/A0.3 $14.24 11/30/202220,000 shares $261.38 thousand +455.6%N/A1.6 $13.07 11/15/20223,600 shares $48.20 thousand +71.4%N/A0.2 $13.39 10/31/20222,100 shares $25.73 thousand +23.5%N/A0.2 $12.25 10/15/20221,700 shares $19.99 thousand -65.3%N/A0.2 $11.76 9/30/20224,900 shares $57.33 thousand +145.0%N/A0.8 $11.70 9/15/20222,000 shares $30.14 thousand -33.3%N/A0.1 $15.07 8/31/20223,000 shares $41.10 thousand -44.4%N/A0.1 $13.70 8/15/20225,400 shares $74.66 thousand -57.5%N/A0.4 $13.83 7/31/202212,700 shares $165.10 thousand -22.6%N/A0.7 $13.00 7/15/202216,400 shares $189.58 thousand -18.0%N/A1.7 $11.56 6/30/202220,000 shares $205.40 thousand -19.7%N/A1.9 $10.27 6/15/202224,900 shares $242.78 thousand -23.4%N/A1.7 $9.75 5/31/202232,500 shares $372.52 thousand +164.2%N/A1.1 $11.46 5/15/202212,300 shares $143.17 thousand -54.8%N/A1.1 $11.64 4/30/202227,200 shares $316.06 thousand +26.5%N/A3.2 $11.62 4/15/202221,500 shares $281.78 thousand -2.7%N/A1.8 $13.11 3/31/202222,100 shares $308.30 thousand +50.3%N/A0.7 $13.95 3/15/202214,700 shares $218.74 thousand -47.7%N/A1.2 $14.88 2/28/202228,100 shares $417.29 thousand +19.1%N/A1.7 $14.85 2/15/202223,600 shares $383.49 thousand +17.4%N/A1.7 $16.25 1/31/202220,100 shares $332.66 thousand +125.8%N/A0.9 $16.55 1/15/20228,900 shares $162.16 thousand +74.5%N/A1.1 $18.22 12/31/20215,100 shares $101.54 thousand +96.2%N/A1.4 $19.91 12/15/20212,600 shares $52.52 thousand No ChangeN/A0.3 $20.20 11/30/20212,600 shares $52.96 thousand -36.6%N/A0.4 $20.37 11/15/20214,100 shares $99.26 thousand +272.7%N/A0.3 $24.21 10/29/20211,100 shares $32.02 thousand No ChangeN/A0.3 $29.11 9/30/2021700 shares $21.13 thousand +600.0%N/A0 $30.19 9/15/2021100 shares $2.97 thousand -98.8%N/A0 $29.65 8/31/20218,100 shares $219.51 thousand +80.0%N/A0.3 $27.10 8/13/20214,500 shares $90.81 thousand -2.2%N/A1.9 $20.18 7/30/20214,600 shares $94.10 thousand -44.6%N/A0.4 $20.46 7/15/20218,300 shares $173.39 thousand +102.4%N/A0.9 $20.89 6/30/20214,100 shares $93.69 thousand +17.1%N/A0.2 $22.85 6/15/20213,500 shares $75.43 thousand +400.0%N/A0.4 $21.55379 passengers walked away from this (Ad)Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists[See The Details Here] 5/28/2021700 shares $15.88 thousand +16.7%N/A0.1 $22.69 5/14/2021600 shares $12.92 thousand -50.0%N/A0.1 $21.53 4/30/20211,200 shares $27.98 thousand No ChangeN/A0.2 $23.32 3/31/20212,000 shares $40.46 thousand -42.9%N/A0.2 $20.23 3/15/20213,500 shares $68.60 thousand -39.7%N/A0.2 $19.60 2/26/20215,800 shares $97.38 thousand +5,700.0%N/A0.6 $16.79 2/12/2021100 shares $1.65 thousand No ChangeN/A0 $16.45 11/30/20203,000 shares $45.51 thousand -30.2%N/A0.7 $15.17 11/15/20204,300 shares $64.50 thousand +16.2%N/A0.5 $15.00 10/30/20203,700 shares $56.31 thousand +48.0%N/A0.8 $15.22 10/15/20202,500 shares $41.28 thousand +2,400.0%N/A1 $16.51 9/30/2020100 shares $1.62 thousand -99.1%N/A0 $16.18 CLVLY Short Interest - Frequently Asked Questions What is Clinuvel Pharmaceuticals' current short interest? Short interest is the volume of Clinuvel Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 6,300 shares of CLVLY short. Learn More on Clinuvel Pharmaceuticals' current short interest. What is a good short interest ratio for Clinuvel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLVLY shares currently have a short interest ratio of 9.0. Learn More on Clinuvel Pharmaceuticals's short interest ratio. Is Clinuvel Pharmaceuticals' short interest increasing or decreasing? Clinuvel Pharmaceuticals saw a increase in short interest in May. As of May 31st, there was short interest totaling 6,300 shares, an increase of 3.3% from the previous total of 6,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Clinuvel Pharmaceuticals stock? Short selling CLVLY is an investing strategy that aims to generate trading profit from Clinuvel Pharmaceuticals as its price is falling. CLVLY shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clinuvel Pharmaceuticals? A short squeeze for Clinuvel Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLVLY, which in turn drives the price of the stock up even further. How often is Clinuvel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLVLY, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Squeeze AGNPF Short Squeeze AKBLF Short Squeeze APLMW Short Squeeze ASPHF Short Squeeze ASCLF Short Squeeze AVCTF Short Squeeze AWKNF Short Squeeze AXIM Short Squeeze BCTXW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CLVLY) was last updated on 6/20/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWar-Proof Power Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinuvel Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Clinuvel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLVLY Stock Free CLVLY Stock Alerts